The dominant IgG1 and IgG3 antibodies can bind to the Fcγ receptor (FcγR) and trigger ADCC and antibody-mediated phagocytosis and mediate complement-based cytotoxicity to kill tumor cells [42]. The gene discussed is IGHG3; the disease is neoplasm.